SCHEMBL7285287

SCHEMBL7285287

COc1cccc2c3c(n(C)c12)CCNC3=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.49
NQO2 P16083 1/20 0.49
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
CASP1 P29466 1/20 0.43
HTT P42858 1/20 0.43
CASP7 P55210 1/20 0.43
ATM Q13315 1/20 0.43
HSD17B10 Q99714 1/20 0.43
BRD4 O60885 4/20 0.40
BCHE P06276 3/20 0.40
ACHE P22303 2/20 0.40
PRMT1 Q99873 1/20 0.40
HTR5A P47898 1/20 0.39
JAK2 O60674 1/20 0.39
BTK Q06187 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7292567 0.82 MCHR1 (0.52) HTTBRD4BCHEACHEALB
SCHEMBL7286561 0.82 PARP1 (0.45) BRD4BCHEACHEBRD2BRD3
SCHEMBL7282759 0.81 PARP10 (0.44) BRD4BCHEACHEBRD2BRD3
SCHEMBL7285339 0.81 BRD4 (0.42) BRD4BCHEACHEJAK2BTK
SCHEMBL7294670 0.77 PARP10 (0.50) BRD4BCHEACHEBRD2BRD3
SCHEMBL7302751 0.77 BRD4 (0.40) BRD4BCHEACHEJAK2BRD2
SCHEMBL7294032 0.75 BCHE (0.49) BCHEACHEALBMCHR1
SCHEMBL918 0.74 BRD4 (0.57) KDM4EHSD17B10BRD4BCHEACHE
SCHEMBL915093 0.72 PARP10 (0.47) CYP19A1PDE4B
SCHEMBL7294857 0.71 MAPKAPK2 (0.50) NQO2KDM4EALDH1A1HPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353983-B1 Lactam derivatives GLAXO GROUP LTD (GB) 1996-05-29 EP disclosed
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed
EP-0353983-A2 Lactam derivatives GLAXO GROUP LIMITED (GB) 1990-02-07 EP disclosed